Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dun & Bradstreet Corp (DNB) Gets A Poor Rating: Equifax Inc. (EFX), Moody’s Corporation (MCO)

Page 1 of 2

Dun & Bradstreet Corp (NYSE:DNB)tanked earlier this month after posting fourth quarter numbers below Wall Street expectations, which was a result of weakness in its North American business. D&B’s stock fell more than 7%, but I think it’s worth taking a look at the company to see if it could be a buy on the weakness (check out the hedge funds owning Dun & Bradstreet). However, I have my doubts that I can convince investors to buy into the stock.

Dun & Bradstreet Corp (NYSE:DNB)The earnings numbers. The numbers appear to have missed across the board, on sales, operating income and EPS. Sales came in at $463 million, short of $479 million consensus; operating income was $172 million, below consensus of $176 million; and actual EPS was $2.38, short of the Street estimates of $2.47. D&B’s business has been hit hard due to a contraction in business spending. Other notable headwind for D&B is high debt levels, where total debt is at almost $900 million, versus $860 million in the previous quarter. The company’s debt ratio is over 140% due to its relatively high debt load and negative equity, where its stockholders’ equity is at negative $770 million.

Increasing competition will also pressure D&B profitability and margins going forward. The competition includes major corporate information gathering companies Equifax Inc. (NYSE:EFX), Moody’s Corporation (NYSE:MCO), Fair Issac Corporation (NYSE:FICO) and Axiom . Equifax has a large reliance on the mortgage industry, which has proved troublesome for the company, especially with the decline in home purchases. Equifax’s earnings for last quarter came in at $2.20 per share, up from $1.93 per share for the same quarter last year, but still well below analysts’ estimates of $2.46 (read more about the new-age ratings agencies). Equifax also offers corporate credit rating services, which more directly compete with D&B.

Moody’s stock has fallen more than 10% over the past few days on news that S&P, fellow major rating agency, was being sued by the Department of Justice, claiming that the agency knowing attached faulty ratings to structured finance products. Although the DOJ has made no mention of dragging Moody’s into the suit, the stock remains depressed on concerns that the company could be involved. The business of being a major credit rating agency involves high barriers to entry, which provides some insulation to Moody’s business. Despite the DOJ overhang, the stock trades with a PEG that is only 0.9 (a PEG below 1.0 suggests the stock is a solid growth at a reasonable price opportunity).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!